69.39 F
February 28, 2024
Image default

Pfizer says COVID-19 pill near 90% effective in final analysis

Published by

By Michael Erman and Deena Beasley NEW YORK (Reuters) -Pfizer Inc on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus. The U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. The data disclosed on Tuesday includes an additional 1,…

Read More

Related posts

Calls for ceasefire in Ethiopia grow amid deepening conflict


Ukraine and Russia: What you need to know right now


Biden lands in Europe in middle of dispute over Russian energy sanctions


Biden announces new $700 million in military aid for Ukraine


Kremlin critic Navalny rallies supporters after new nine-year sentence


NATO vows more help for Ukraine, begins planning to adapt to ‘new reality’


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.